Does a clinical trial render the pharmaceutical formulation used therein public?
OLG Celle on the obligations of distributors under Art. 14 MDR when distributing non-compliant medical devices in the context of unfair competition law
by Dr. Daniel Tietjen and Sherin Sayed
Is it 'unfair' for a university to own student-created IP? Reflections on OUI v ONI
by Adrian Toutoungi and Lauren Mounteney
Disproportionality in Pharma-Cases: A Follow-up
by Verena Bertram and Dr. Nora E. Wessendorf, LL.M. (Washington)
Dos & Don’ts in Research Collaborations
Are your contracts UPC ready? How to triage your key IP agreements and templates
by multiple authors
The impact of the National Security and Investment Act 2021
by Philip Shepherd and Paolo Palmigiano
Are your contracts UPC ready? Key risks to consider
by multiple authors
Means of evidence before the UPC
by multiple authors
How do inspections work in the UPC?
by multiple authors
Should I file an infringement action with the UPC or stick to national courts?
A comparison of UPC infringement proceedings with national patent infringement proceedings
by multiple authors
Long-running issue: the distinction between cosmetic products and medicinal products by function
by Dr. Manja Epping and Sherin Sayed